
Immunogenicity of Standard‐Titer Measles Vaccine in HIV‐1–Infected and Uninfected Zambian Children: An Observational Study
Author(s) -
William J. Moss,
Susana Scott,
Nanthalile Mugala,
Zaza M. Ndhlovu,
Judy A. Beeler,
Susette Audet,
Mirriam Ngala,
Sheila Monde Mwangala,
Chansa Nkonga-Mwangilwa,
Judith J. Ryon,
Mwaka Monze,
Francis Kasolo,
Thomas C. Quinn,
Simon Cousens,
Diane E. Griffin,
Felicity Cutts
Publication year - 2007
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/519169
Subject(s) - immunogenicity , virology , measles , titer , medicine , measles vaccine , observational study , immunology , vaccination , virus , antibody
Achieving the level of population immunity required for measles elimination may be difficult in regions of high human immunodeficiency virus type 1 (HIV-1) prevalence, because HIV-1-infected children may be less likely to respond to or maintain protective antibody levels after vaccination.